Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus
β Scribed by Richard J. Morris; Curt R. Freed; Peter F. Kohler
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 286 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To test the hypotheses that there is an excess percentage of slow acetylators among patients with idiopathic systemic lupus erythematosus (SLE) and that these patients had excessive exposure to environmental amines and hydrazines before the onset of illness. Methods. Case-control study with structu
We describe a patient with systemic lupus erythematosus who, after a disease flare, sequentially produced antibodies to specific Sm polypeptides (demonstrated by counterimmunoelectrophoresis, immunoblotting, and RNA immunoprecipitation) concomitantly with the disappearance of anti-double-stranded DN